Neutrophils aid in protection of the vaginal mucosae of immune mice against challenge with herpes simplex virus type 2

Journal of Virology

Volumn 73, Issue 8, 1999, Pages 6380-6386

  Milligan, Gregg N ^a,b  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; VIRUS ANTIBODY;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY PRODUCTION; ANTIVIRAL ACTIVITY; ARTICLE; B LYMPHOCYTE; CELL INFILTRATION; CELL LOSS; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HERPES SIMPLEX VIRUS 2; IMMUNOSTIMULATION; INOCULATION; MOUSE; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; VAGINA MUCOSA; VIRUS IMMUNITY; VIRUS LOAD;

EID: 0032804392     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.8.6380-6386.1999     Document Type: Article

References (43)

1. Barteneva, N., I. Theodor, E. M. Peterson, and L. M. de la Maza. 1996. Role of neutrophils in controlling early stages of a Chlamydia trachomatis infection. Infect. Immun. 64:4830-4833.
2. Boddingius, J., H. Dijkman, E. Hendriksen, R. Schift, and E. Stolz. 1987. HSV-2 replication sites, monocyte and lymphocytic cell infection and virion phagocytosis by neutrophils, in vesicular lesions on penile skin. Electronoptical studies of a biopsy. J. Cutan. Pathol. 14:165-175.
3. Cassatella, M. A. 1995. The production of cytokines by polymorphonuclear neutrophils. Immunol. Today 16:21-26.
4. Cassatella, M. A., L. Meda, S. Gasperini, A. D'Andrea, X. Ma, and G. Trinchieri. 1995. Interleukin-12 production by human polymorphonuclear leukocytes. Eur. J. Immunol. 25:1-5.
5. Champlin, A. K., D. L. Dorr, and A. H. Gates. 1974. Determining the stage of estrous cycle in the mouse by the appearance of the vagina. Biol. Reprod. 8:491-494.
6. Conlan, J. W. 1997. Critical roles of neutrophils in host defense against experimental systemic infections of mice by Listeria monocytogenes, Salmonella typhimurium, and Yersinia enterocolitica. Infect. Immun. 65:630-635.
7. Daher, K. A., M. E. Selsted, and R. I. Lehrer. 1986. Direct inactivation of viruses by human granulocyte defensins. J. Virol. 60:1068-1074.
8. Ganz, T., M. E. Selsted, D. Szklarek, S. S. Harwig, K. Daher, D. F. Bainton, and R. I. Lehrer. 1985. Defensins. Natural peptide antibiotics of human neutrophils. J. Clin. Investig. 76:1427-1435.
9. Hestdal, K., F. W. Ruscetti, J. N. Ihie, S. E. W. Jacobsen, C. M. Dubois, W. C. Kopp, D. C. Longo, and J. R. Keller. 1991. Characterization and regulation of RB6-8C5 antigen expression on murine bone marrow cells. J. Immunol. 147:22-28.
10. Hill, T. J. 1985. Herpes simplex virus latency, p. 175. In B. Roizman (ed.), The herpesviruses, vol. 3. Plenum Press, New York, N.Y.
11. Holmberg, S. D., J. A. Stewart, and A. R. Gerber. 1988. Prior herpes simplex virus type 2 infection as a risk factor for HIV infection. JAMA 259:1048-1050.
12. Huff, J. C., G. G. Krueger, J. C. Overall, J. Copeland, and S. L. Spruance. 1981. The histopathologic evolution of recurrent herpes simplex labialis. J. Am. Acad. Dermatol. 5:550-557.
13. Klebanoff, S. J., M. A. Vadas, J. M. Harlan, L. H. Sparks, J. R. Gamble, J. M. Agosti, and A. M. Waltersdorph. 1986. Stimulation of neutrophils by tumor necrosis factor. J. Immunol. 136:4220-4225.
14. Klotzbucher, A., S. Mittnacht, H. Kirchner, and H. Jacobsen. 1990. Different effects of IFN-γ and IFNα/β on "immediate early" gene expression of HSV-1. Virology 179:487-491.
15. Lopez, A. D., D. J. Williamson, J. R. Gamble, C. G. Begley, J. M. Harlan, S. J. Klebanoff, A. Waltersdorph, G. Wang, S. C. Clark, and M. A. Vadas. 1986. Recombinant human granulocyte-macrophage colony-stimulating factor stimulates in vitro mature human neutrophil and eosinophil function, surface receptor expression, and survival. J. Clin. Investig. 78:1220-1228.
16. McDermott, M. R., J. R. Smiley, P. Leslie, J. Brais, H. E. Rudzroga, and J. Bienenstock. 1984. Immunity in the female genital tract after intravaginal vaccination of mice with an attenuated strain of herpes simplex virus type 2. J. Virol. 51:747-753.
17. Milligan, G. N. Unpublished data.
18. Milligan, G. N., and D. I. Bernstein. 1995. Analysis of herpes simplex virus-specific T cells in the murine female genital tract following genital infection with herpes simplex virus type 2. Virology 212:481-489.
19. Milligan, G. N., and D. I. Bernstein. 1997. Interferon-γ enhances resolution of herpes simplex virus type 2 infection of the murine genital tract. Virology 229:259-268.
20. Milligan, G. N., D. Bernstein, and N. Bourne. 1998. T lymphocytes are required for protection of the vaginal mucosae and sensory ganglia of immune mice against reinfection with herpes simplex virus type 2. J. Immunol. 160:6093-6100.
21. Nandi, D., and J. P. Allison. 1994. Characterization of neutrophils and T lymphocytes associated with the murine vaginal epithelium. Reg. Immunol. 5:332-338.
22. Oleske, J. M., R. B. Ashman, S. Kohl, S. L. Shore, S. E. Starr, P. Wood, and A. J. Nahmias. 1977. Human polymorphonuclear leucocytes as mediators of antibody dependent cellular cytotoxicity to herpes simplex virus-infected cells. Clin. Exp. Immunol. 27:446-453.
23. Parr, M. B., L. Kepple, M. R. McDermott, M. D. Drew, J. J. Bozzola, and E. L. Parr. 1994. A mouse model for studies of mucosal immunity to vaginal infection by herpes simplex virus type 2. Lab. Investig. 70:369-380.
24. Parr, M. B., and E. L. Parr. 1998. Mucosal immunity to herpes simplex virus type 2 infection in the mouse vagina is impaired by in vivo depletion of T lymphocytes. J. Virol. 72:2677-2685.
25. Perussia, B., M. Kobayaski, M. E. Rossi, I. Anegon, and G. Trinchieri. 1987. Immune interferon enhances properties of human granulocytes: role of Fc receptors and effects of lymphotoxin, tumor necrosis factor, and granulocyte macrophage colony-stimulating factor. J. Immunol. 138:765-774.
26. Shalaby, M. R., B. B. Aggarwal, E. Rinderknecht, L. P. Sveersky, B. S. Findle, and M. A. Palladino, Jr. 1985. Activation of human polymorphonuclear neutrophil functions by interferon-gamma and tumor necrosis factors. J. Immunol. 135:2069-2073.
27. Shalaby, M. R., M. A. Palladino, S. E. Hirabayashi, T. E. Eassalu, G. D. Lewis, H. M. Shephard, and B. B. Aggarwal. 1987. Receptor binding and activation of polymorphonuclear neutrophils by tumor necrosis factor-alpha. J. Leukoc. Biol. 41:196-204.
28. Siebens, H., S. S. Tevethia, and B. M. Babior. 1979. Neutrophil-mediated antibody-dependent killing of herpes simplex-virus infected cells. Blood 54:88-94.
29. Sonoda, Y., N. Mukalda, J.-B. Wang, M. Shimada-Hiratsuka, M. Naito, T. Kasahara, A. Harada, M. Inoue, and K. Matsushima. 1998. Physiologic regulation of postovulatory neutrophil migration into vagina in mice by a C-X-C chemokine(s). J. Immunol. 160:6159-6165.
30. Stanberry, L. R., S. Kit, and M. G. Myers. 1985. Thymidine kinase-deficient herpes simplex virus type 2 genital infection in guinea pigs. J. Virol. 55:322-328.
31. Stanberry, L. R., D. I. Bernstein, S. Kit, and M. G. Myers. 1986. Genital reinfection after recovery from initial genital infection with herpes simplex virus type 2 in guinea pigs. J. Infect. Dis. 153:1055-1061.
32. Steinbeck, M. J., and J. A. Roth. 1989. Neutrophil activation by recombinant cytokines. Rev. Infect. Dis. 11:549-568.
33. Stevens, J. G., and M. L. Cook. 1971. Latent herpes simplex in spinal ganglia of mice. Science 173:843-845.
34. Stevens, J. G. 1989. Human herpesvirus: a consideration of the latent state. Microbiol. Rev. 53:318-332.
35. Thomas, J., S. Gangappa, S. Kanangat, and B. T. Rouse. 1997. On the essential involvement of neutrophils in the immunopathologic disease herpetic stromal keratitis. J. Immunol. 158:1383-1391.
36. Tumpey, T. M., S. H. Chen, J. E. Oakes, and R. N. Lausch. 1996. Neutrophil-mediated suppression of virus replication after herpes simplex virus type 1 infection of the murine cornea. J. Virol. 70:898-904.
37. Van Strijp, J. A., K. P. Van Kessel, M. E. van der Tol, A. C. Fluit, H. Snippe, and J. Verhoef. 1989. Phagocytosis of herpes simplex virus by human granulocytes and monocytes. Arch. Virol. 104:287-298.
38. Vassiloyanakopoulos, A. B., S. Okamoto, and J. Fierer. 1998. The crucial role of polymorphonuclear leukocytes in resistance to Salmonella dublin infections in genetically susceptible and resistant mice. Proc. Natl. Acad. Sci. USA 95:7676-7681.
39. Walz, M. A., R. W. Price, K. Hayashi, B. J. Katz, and A. L. Notkins. 1977. Effect of immunization on acute and latent infections of vaginouterine tissue with herpes simplex virus types 1 and 2. J. Infect. Dis. 135:744-752.
40. Wasserheit, J. N. 1992. Epidemiological synergy: interrelationships between human immunodeficiency virus infection and other sexually transmitted diseases. Sex. Transm. Dis. 19:61-77.
41. Weisbart, R. H., D. W. Gholde, S. C. Clark, G. G. Wang, and J. H. C. Gasson. 1985. Human granulocyte-macrophage colony-stimulating factor is a neutrophil activator. Nature 314:361-363.
42. Wrzos, H., and F. Rapp. 1985. Experimental model for activation of genital herpes simplex virus. J. Infect. Dis. 151:349-354.
43. Yeaman, G. R., J. E. Collins, J. K. Currie, P. M. Guyre, C. R. Wira, and M. W. Fanger. 1998. IFN-γ is produced by polymorphonuclear neutrophils in human uterine endometrium and by cultured peripheral blood polymorphonuclear neutrophils. J. Immunol. 160:5145-5153.